Drug
Albumin infusion
Albumin infusion is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_2
2
50%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
unknown2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 22 (66.7%)
Phase 31 (33.3%)
Trials by Status
unknown250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_2
Modulation of Cerebral Ischemia by Albumin
NCT07415655
recruitingphase_2
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
NCT06052176
unknown
Albumin Infusion in Inpatients With Decompensated Cirrhosis
NCT05719051
unknownphase_3
Albumin for Hepatocellular Carcinoma
NCT03974074
Clinical Trials (4)
Showing 4 of 4 trials
NCT07415655Phase 2
Modulation of Cerebral Ischemia by Albumin
NCT06052176Phase 2
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
NCT05719051
Albumin Infusion in Inpatients With Decompensated Cirrhosis
NCT03974074Phase 3
Albumin for Hepatocellular Carcinoma
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4